Cresco Labs Inc-subordinate (CRLBF) — Who's Buying and Selling (13F, Q2 2026)

CRLBF ranks #10937 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

7 institutions disclose a position in CRLBF, but none treat it as a major bet — even Albert D Mason Inc, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Albert D Mason Inc has trimmed its CRLBF position for two straight quarters, cutting it by $39.1K while still holding $73.1K.

CRLBF reported a net loss of $135.4M in its latest fiscal year.

• Not yet profitable — net loss of $135.4M in the latest fiscal year
• Revenue declined 9.5% year over year
• Net income declined year over year, from -$74.4M to -$135.4M
• Generated $72.9M in positive operating cash flow
• Current ratio of 2.59x — enough short-term assets to cover short-term liabilities
• Liabilities run 3.74x equity — a highly leveraged balance sheet worth noting